Handok
Korea - SeoulBiotechnology
Focus: Handok is a Seoul-based biotechnology company with a diverse portfolio spanning small molecules, biologics, and devices across multiple therapeutic areas. The company maintains an active clinical pipeline with 47 trials across Phase 1-4 and observational studies.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Handok
AI assessmentNot HiringNo open roles listed right now. Follow Handok to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
9 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)
HypertensionClinical Trials (1)
NCT02024100Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)
N/AHelp build intelligence for Handok
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.